|
Publication of the latest clinical results of the Translumina polymer-free rapamycin-coated Yukon stent in JACC cardiovascular Interventions (R.Byrne et al, 2009, 2, 291-299). The German Heart Centre Munich investigated the long-term anti-restenotic efficacy of three different DES, the polymer-based Cypher and Taxus versus the polymer-free Yukon DES. The Yukon DES showed statistically significant less delayed angiographic restenosis and late lumen loss in the period between 6-8 months and the 2-years follow-up. For details please refer to the clinical abstract section. |
|
